MTOR and cancer: The contribution of the phophatidylinositide-3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) axis to survivin expression is observed not only in various cancer cells [28, 29], but also in normal cells including cardiac myocytes [30].